Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Seebri Neohaler

Drug Respiratory

NDC 63402-815-60

Open in the dashboard

General payments

$59,602

3,671 payments

Research payments

$0

0 payments

Through program year 2020, $59,602 in general payments and $0 in research payments were reported against Seebri Neohaler (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $56,251 3,453
2019 General $3,351 218

Breakdown

Who paid General payments · program years 2019–2020
  1. Sunovion Pharmaceuticals Inc. $59,602 3,671 payments
Top recipients General payments · program year 2020
  1. Sandra Schuldheisz Somerset, KY $473 <1% · 29 payments
  2. Sanober Kable Pulmonary Disease · Denison, TX $344 <1% · 54 payments
  3. Vijay Patel Pulmonary Disease · Newnan, GA $294 <1% · 17 payments
  4. Shankar Kandaswamy Pulmonary Disease · Newnan, GA $276 <1% · 17 payments
  5. Mythili Venkataraman Pulmonary Disease · Plano, TX $240 <1% · 44 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pulmonary Disease Internal Medicine $25,293 45% · 630 practitioners
  2. Family Medicine $11,479 21% · 378 practitioners
  3. Internal Medicine $11,055 20% · 342 practitioners
  4. Critical Care Medicine Internal Medicine $2,610 5% · 77 practitioners
  5. Sleep Medicine Internal Medicine $976 2% · 24 practitioners

The top 5 of 37 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Florida $5,100 9% · 130 recipients
  2. Virginia $3,951 7% · 89 recipients
  3. Tennessee $3,724 7% · 90 recipients
  4. New York $3,367 6% · 63 recipients
  5. North Carolina $3,270 6% · 119 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

3,671 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record